6P Unveiling the impact of intra-tumor heterogeneity in treatment response to achieve personalized medicine for endometrial cancer patients

MLA

B. Villafranca Magdalena, et al. “6P Unveiling the Impact of Intra-Tumor Heterogeneity in Treatment Response to Achieve Personalized Medicine for Endometrial Cancer Patients.” ESMO Open, vol. 8, Feb. 2023, p. 100860. EBSCOhost, https://doi.org/10.1016/j.esmoop.2023.100860.

APA

B. Villafranca Magdalena, M. Denizli, C. Masferrer-Ferragutcasas, M. Rebull, G. Parra, Á. García, S. Cabrera, A. Gil-Moreno, C.P. Moiola, & E. Colas. (2023). 6P Unveiling the impact of intra-tumor heterogeneity in treatment response to achieve personalized medicine for endometrial cancer patients. ESMO Open, 8, 100860. https://doi.org/10.1016/j.esmoop.2023.100860

Chicago

B. Villafranca Magdalena, M. Denizli, C. Masferrer-Ferragutcasas, M. Rebull, G. Parra, Á. García, S. Cabrera, A. Gil-Moreno, C.P. Moiola, and E. Colas. 2023. “6P Unveiling the Impact of Intra-Tumor Heterogeneity in Treatment Response to Achieve Personalized Medicine for Endometrial Cancer Patients.” ESMO Open 8 (February): 100860. doi:10.1016/j.esmoop.2023.100860.